Prescription drug · ANDA
Benztropine Mesylate NDC 68475-512
Benztropine mesylate 1 mg/mL · Injection · Intramuscular, Intravenous · Navinta LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68475-512-02 | 6847505120268475051202 | 5 VIAL in 1 CARTON (68475-512-02) / 2 mL in 1 VIAL (68475-512-01)Marketed from Nov 24, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Benztropine Mesylate
- Generic name (nonproprietary)
- benztropine mesylate
- Active ingredients
- Benztropine mesylate — 1 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Labeler
- Navinta LLCNDC labeler code 68475
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 091525
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Antagonists (Mechanism)Histamine Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 68475-512_29929540-0861-42fa-9b0b-6675023ee007SPL ID 29929540-0861-42fa-9b0b-6675023ee007SPL set ID f92fbafa-314d-4449-831f-26108339e6b2RxCUI 885205UNII WMJ8TL7510UPC 0368475512016
- Pharmacologic class
- Anticholinergic; Antihistamine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N468475051202followed by a unit qualifier and the quantityPackage 68475-0512-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS For use as an adjunct in the therapy of all forms of parkinsonism (see DOSAGE AND ADMINISTRATION ). Useful also in the control of extrapyramidal disorders (except tardive dyskinesia — see PRECAUTIONS ) due to neuroleptic drugs (e.g., phenothiazines).
Excerpt only. Read the full label for complete information.
About NDC 68475-512
- What is NDC 68475-512?
- 68475-512 is the product NDC for Benztropine Mesylate, Benztropine mesylate 1 mg/mL injection, listed with the FDA by Navinta LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Benztropine Mesylate.
- What is the active ingredient?
- Benztropine mesylate.
- Who is the labeler?
- Navinta LLC, NDC labeler code 68475. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Benztropine Mesylate?
- 55 other product NDCs are listed under this name. See all Benztropine Mesylate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Benztropine Mesylate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Benztropine Mesylate | Benztropine mesylate 1 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-012 | 87441-0012-01 |
| Benztropine Mesylate | Benztropine mesylate 2 mg/1 | TabletOral | Coupler LLC | 67046-0040 | 67046-0040-03 |
| Benztropine Mesylate | Benztropine mesylate 2 mg/1 | TabletOral | Coupler LLC | 67046-1675 | 67046-1675-03 |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | Coupler LLC | 67046-1205 | 67046-1205-03 |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | Coupler LLC | 67046-1674 | 67046-1674-03 |
| Benztropine Mesylate | Benztropine mesylate 1 mg/1 | TabletOral | Coupler LLC | 67046-0041 | 67046-0041-03 |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | QUAGEN PHARMACEUTICALS LLC | 70752-123 | 70752-0123-1070752-0123-11 |
| Benztropine Mesylate | Benztropine mesylate 1 mg/1 | TabletOral | QUAGEN PHARMACEUTICALS LLC | 70752-124 | 70752-0124-1070752-0124-11 |
| Benztropine Mesylate | Benztropine mesylate 2 mg/1 | TabletOral | QUAGEN PHARMACEUTICALS LLC | 70752-125 | 70752-0125-1070752-0125-11 |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-2594 | 72162-2594-0072162-2594-0172162-2594-02 |
Other NDCs under ANDA 091525
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Benztropine Mesylate | Benztropine mesylate 1 mg/mL | InjectionIntramuscular, Intravenous | Zydus Pharmaceuticals USA Inc. | 68382-860 |